Hypotaurine Market REPORT OVERVIEW
- Request Free Sample PDF to learn more about this report
The global hypotaurine market size was USD 234 million in 2021 and market is projected to touch USD 354.34 million by 2031, exhibiting a CAGR of 4.2% during the forecasting period.
The sudden spike in CAGR is attributed to the market's growth and demand returning to pre-pandemic levels once the pandemic is over.
A natural amino acid called hypotaurine has been shown to be successful in the treatment of stress and anxiety. Additionally, it is believed to enhance memory and cognitive performance. A sulfinic acid called hypotaurine is a step in the production of taurine. Similar to taurine, it operates on glycine receptors to function as an endogenous neurotransmitter. It is an osmolyte with anti-inflammatory qualities. Cysteine serves as its source. It is biosynthesized in the pancreas of mammals from cysteine. The enzyme cysteine dioxygenase catalyses the initial oxidation of cysteine to its sulfinic acid in the cysteine sulfinic acid pathway. Sulfinoalanine decarboxylase then decarboxylates cysteine sulfinic acid to produce the chemical. Its dehydrogenase oxidises it enzymatically to produce taurine.
COVID-19 Impact: Halt on Supply Chain Due to Lockdown to Hamper Market Growth
Supply chains of the chemical are linked, and China continues to be a key component. Transportation has ceased as a result of the lockdown of cities and nations. There are countless chemical enterprises that have temporarily closed or are about to do so. Companies that rely heavily on Chinese manufacturing for raw materials, components, or finished items will be most negatively affected. The coronavirus outbreak's impact on global supply chains has forced hypotaurine market producers to reconsider their manufacturing plans and move production to low-risk regions.
These unanticipated shifts have caused speciality chemical manufacturing companies to postpone their expansion plans, which has hurt the supply environment. The industry has fared better than most others as a result of the slowdown in some segments being countered by an uptick in others. The chemical industry is being keenly studied for any signs of a recovery because it is a leading indicator of industrial activity. The industry is positioned to reap the benefits of any resurgence earliest because of its strong supply side.
LATEST TRENDS
"Assistance of the Chemical in Sperm Motility to Augment Market Growth"
In the Fert- tyrode albumin lactate pyruvate (TALP) fertilisation medium, which is used in in-vitro fertilisation and the assessment of embryo growth, it has been included as a supplement. Additionally, it serves as an H2S scavenger. The starting material for the synthesis of taurine is hypotaurine, a cystamine analogue. Cells are shielded from oxidative damage by its capacity to function as an antioxidant and singlet oxygen scavenger. According to reports, the chemical is crucial for maintaining and promoting sperm motility, as well as for in vitro fertilisation and embryo development. The use of this chemical in vitro fertilisation has recently become a trend.
Hypotaurine Market SEGMENTATION
- Request Free Sample PDF to learn more about this report
-
By Type
Based on type; the market is divided into ≥98% and Others.
In terms of product, ≥98% is the largest segment.
-
By Application
Based on application; the market is divided into healthy food, drink, feed, medicine and other.
In terms of application, drink is the largest segment.
DRIVING FACTORS
"Numerous Applications of the Chemical to Enhance Market Sales"
The primary application sectors of the worldwide market were healthy food, drink, feed, and medical. Due to its widespread use as an expectorant and cough suppressant, medicine is the largest sector. Its usage as a preservative in pharmaceuticals and cosmetics is among its further uses. With rising demand for cosmetic items throughout numerous regions, including Asia Pacific and others, the other uses are anticipated to expand. This is the major factor responsible for hypotaurine market growth.
"The Adoption of the Chemical in Healthcare to Promote Market Growth"
In the spinal cord, hypotaurine exhibits antinociceptive effects on temperature, mechanical, and chemical nociception. It reduces mechanical allodynia and thermal hyperalgesia in CCI rats. It is used intravenously reduces neuropathic, inflammatory, and acute pain. By stimulating glycinergic spinal cord neurons, it may physiologically control nociceptive transmission. The synthesis reactions are used in reverse during taurine breakdown, primarily in the liver. Molybdenum is a cofactor for hypotaurine dehydrogenase, which lowers taurine once more to hypotaurine, which can then be transformed by sulfinoalanine decarboxylase to cysteine sulfinate (sulfinoalanine).
RESTRAINING FACTORS
"Overdose of the Chemical in Human Body to Restrain Market Growth"
The chemical is concentrated into rat placental trophoblast which makes it a little dangerous to human body. The chemical should be used in small proportions or quantities otherwise it can result in paralysis or brain haemorrhage. The chemical should only be used by professionals and handled with care which makes the availability of the product less and requires a licence.
Hypotaurine Market REGIONAL INSIGHTS
- Request Free Sample PDF to learn more about this report
"Asia Pacific to Dominate the Market Due to Rise in Demand of the Product"
Asia pacific owns the largest proportion of hypotaurine market share. Over the projection period, Asia Pacific is anticipated to be the largest and fastest-growing regional market. The expansion is explained by rising product demand in nations like China and India. In addition, it is projected that expanding population paired with greater health consciousness would fuel industry growth in the years to come. Because Minotaur is widely used by many Asian businesses, the Asia Pacific region accounted for a large portion of global income. Additionally, the presence of significant manufacturers in this area will encourage industry growth during the predicted period.
KEY INDUSTRY PLAYERS
"Rise of Product Demand Among Potential Market Players to Boost Market Growth"
Due to the shift in consumer demand, the hypothetical import/export scenario for the chemical, and the analysis of expanding markets, the hypotaurine (CAS 300-84-5) sector is poised to have a robust growth. The market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to the market.
List of Market Players Profiled
- Qianjiang Yongan Pharmaceutical (China)
- China Grand Pharmaceutical (China)
- Jiangyin Huachang Food Additive (China)
- Jiangsu Yuanyang Pharmaceutical (China)
- Taisho Pharmaceutical (Japan)
- Kasano Kosan Corporation (Japan)
REPORT COVERAGE
With strategic analysis, micro and macro market trend and scenario, pricing analysis, and a comprehensive description of the market circumstances in the projected period, the hypotaurine market research report keeps a close eye on the major competitors. It is an expertly written, in-depth study that emphasises key and secondary drivers, market share, top categories, and regional analysis. The paper also examines prominent actors, significant partnerships, mergers, and acquisitions, as well as popular innovations and business practises. The application segment divides the product's many applications into smaller groups and offers data on each application segment's market share and rate of growth.
REPORT COVERAGE | DETAILS |
---|---|
Market Size Value In |
US$ 234 Million in 2021 |
Market Size Value By |
US$ 354.34 Million by 2031 |
Growth Rate |
CAGR of 4.2% from 2021 to 2031 |
Forecast Period |
2024-2031 |
Base Year |
2023 |
Historical Data Available |
Yes |
Regional Scope |
Global |
Segments Covered |
Type and Application |
Frequently Asked Questions
-
What value is the hypotaurine market expected to touch by 2031?
The global hypotaurine market expected to touch USD 354.34 million by 2031.
-
What CAGR is the hypotaurine market expected to exhibit by 2031?
The hypotaurine market is expected to exhibit a CAGR of 4.2% by 2031.
-
Which are the driving factors of the hypotaurine market?
Numerous applications of the chemical and the adoption of the chemical in healthcare are the driving factors of the hypotaurine market.
-
Which are the top companies operating in the hypotaurine market?
Qianjiang Yongan Pharmaceutical, China Grand Pharmaceutical, Jiangyin Huachang Food Additive, Jiangsu Yuanyang Pharmaceutical, Taisho Pharmaceutical, Kasano Kosan Corporation are the top companies operating in the hypotaurine market.